期刊文献+

复制缺陷型腺病毒载体介导人血管内皮细胞生长因子cDNA促进静脉分叶皮瓣的成活 被引量:2

Replication-defective adenovirus vector-mediated human vascular endothelial cell growth factor cDNA promotes survival of lobulated venous flap
下载PDF
导出
摘要 背景:静脉分叶皮瓣可修复多个手指皮肤软组织缺损,但静脉皮瓣普遍存在成活率不稳定,限制了其在临床上的应用。目的:观察以复制缺陷型腺病毒介导血管内皮细胞生长因子165基因(cDNA)局部应用对兔静脉分叶皮瓣成活的影响。方法:用新西兰大白兔制作侧腹壁双蒂轴型静脉分叶皮瓣,分别皮下注射介导血管内皮细胞生长因子165基因(Ad-VEGF)的复制缺陷型腺病毒、携带β半乳糖苷酶基因的腺病毒(Ad-Gal)和生理盐水。术后7d对3组兔进行皮瓣存活率、免疫组织化学、新生血管计数和常规组织切片的检测。结果与结论:术后7d,Ad-VEGF165组皮瓣成活率和平均血管数目显著高于Ad-Gal组和生理盐水组(P<0.01),皮瓣中血管内皮细胞及毛囊旁细胞中有大量VEGF蛋白阳性表达细胞,皮瓣中出现肉芽组织增生,新生血管大量形成。结果证实,以复制缺陷型腺病毒为载体介导的人VEGFcDNA能促进新生血管的形成并提高静脉分叶皮瓣的成活率。 BACKGROUND: Lobulated venous flap has some unique advantages to repair the soft tissue defects in many fingers. However, the poor viability of venous flaps limits their clinical applications. OBJECTIVE:To explore the effects of replication-defective adenovirus vector-mediated human vascular endothelial cell growth factor (VEGF) gene on survival of lobulated venous flap. METHODS:24 rabbits were randomly divided into three groups. Lateral abdominal wall skin flap was created in rabbits. At 5 days before operation, Ad-VEGF165 (Ad-VEGF165 group), Ad-Gal (Ad-Gal group) and normal saline (NS group) were subcutaneously injected in the skin flap. The survival rate of the flap and the number of the new blood vessels were determined on the 7th day after operation. RESULTS AND CONCLUSION:The flap survival rate was (76.281±2.298)%, (50.408±1.577)% and (48.748±2.130)% in the Ad-VEGF165, Ad-Gal and NS groups, respectively. The number of the new blood vessels was (37.76±2.21) cm2, (22.68±2.15) cm2, and (23.31±3.38)/cm2 in the above-mentioned three groups, respectively. Immunohistochemical staining showed that lots of VEGF was expressed in the Ad-VEGF165 group. Blood vessel hyperplasia was obvious in the Ad-VEGF165 group. The replication-defective adenovirus vector-mediated VEGF gene can increase the neovascularization in lobulated venous flap and augments their survival rate.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第28期5217-5220,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 湖南省卫生厅资助课题(B2006-117)资助~~
  • 相关文献

参考文献16

二级参考文献23

  • 1He TC, Zhou S, da Costa LT, et al. A simplified system for generaring recombinant adenoviruses. Proc Natl Acad Sci USA, 1998, 95 (5) : 2509.
  • 2Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparirvbinding growth factor specific for vascular endothelia cells. Bio chem Biophys Res Cornrnun, 1989, 161(2): 851.
  • 3Whitlock PR, Hackett NR, Leopold PL, et al. Adenovirus-mediated transfer of a minigene expressing multiple isoforrns of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs Mol Ther, 2004, 9(1): 67.
  • 4Pang H, Wright V, Usas A, et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest, 2002, 110(6): 751.
  • 5Wang F, Rendahl KG, Manning WC, et al. AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat. Invest Ophthalmol Vis Sci, 2003, 44(2): 781.
  • 6Kaufman T, Angel MF, Eichenlaub EH, et al. The salutary effects of the bed on the survival of experimental flaps. Ann Plast Surg , 1985,14:64-69.
  • 7Deck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science , 1989, 246: 1309-1312.
  • 8Dvork HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol, 1995,146:1029-1039.
  • 9Hood JD, Meininger CJ, Ziche M, et al. VEGF upregulates ecNOS message, protein and NO production in human endothelial cells. Am J Physiol , 1998,274: H 1054-H1058.
  • 10Murohara T, Horowitz JR, Lilver M, et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation, 1998,97:99-107.

共引文献6

同被引文献21

  • 1Einfeld DA,Roelvink PW.Advances towards target ableadenovirus vectors for gene therapy[J].Cur r Opin MolTher,2002,4(5):444-451.
  • 2Kuhnel F,Schulte B,Wirth T,et al.Protein Transduction DomainsFused to Virus Receptors Improve Cellular Virus Uptake and Enhance Oncolysis by Tumor-Specific Replicating Vectors[J].Virol,2004,78(24):13743-13754.
  • 3Han T,Tang Y,Ugai H,et al.Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transferefficacy[J].Virol J,2007,4:103.
  • 4Yu D,Jin C,Leja J,et al.Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in experimental Neuroblastoma and Neuroendocrine Tumors[J].J Virol,2011,85(24):13114-13123.
  • 5K retz A,Wybranietz WA,Her mening S,et al.HSV-1VP22 Augments Adenoviral Gene Transfer to CNS Neurons in the Retina and Striatum in Vivo[J].Mol Ther,2003,7(5):659-669.
  • 6Chhabra A,Mehrotra S,Chakraborty NG,et al.Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocation[J].Eur J Immunol,2004,34(10):2824-2833.
  • 7Xiong F,Xiao SB,Peng FN,et al.Herpes Simplex Virus VP22 Enhances Adenovirus-Mediated Microdystrophin Gene Transfer to Skeletal Muscles in Dystrophin-Deficient(mdx)Mice[J].Hum Gene Ther,2007,18(6):490-501.
  • 8Xiong F,Xiao S B,Yu M J,et al.Enhanced effect of microdystrophin gene transfection by HSV-VP22mediated intercellular protein transport.[J].BMC Neurosci,2007,8:50.
  • 9Murakami M,Ugai H,Wang MH,et al.An adenoviral vector expressing human adenovirus5and3fiber proteins for targeting heterogeneous cell populations[J].Virology,2010,407(2):196-205.
  • 10谭江琳,彭旭,袁顺宗,等.人P311腺病毒表达载体的构建及表达[A].第八届全国烧伤外科学年会论文汇编[C].2007.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部